Effectiveness of anti-IgE and anti-IL-5 treatment in step 5 asthma patients.

被引：0
|
作者：
Saji, Junko [1 ]
Muraoka, Hiromi [1 ]
Nishimoto, Eriko [1 ]
Matsuzawa, Shin [2 ]
Okamoto, Mariko [2 ]
Inoue, Teppei [2 ]
Handa, Hiroshi [2 ]
Nishine, Hiroki [2 ]
Inoue, Takeo [2 ]
Miyazawa, Teruomi [2 ]
Mineshita, Masamichi [2 ]
机构：
[1] Kawasaki Municipal Tama Hosp, Div Resp Dis, Dept Internal Med, Kawasaki, Kanagawa, Japan
[2] St Marianna Univ, Sch Med, Dept Internal Med, Div Resp Dis, Kawasaki, Kanagawa, Japan
来源：
EUROPEAN RESPIRATORY JOURNAL | 2018年 / 52卷
关键词：
D O I：
10.1183/13993003.congress-2018.PA1131
中图分类号：
R56 [呼吸系及胸部疾病];
学科分类号：
摘要：
PA1131
引用
收藏
页数：2
相关论文
共 50 条
  • [41] Severe and difficult asthma - treatment with anti-IgE
    Jahnz-Rozyk, Karina
    FAMILY MEDICINE AND PRIMARY CARE REVIEW, 2008, 10 (03): : 866 - 869
  • [42] Anti-IgE antibody for the treatment of allergic asthma
    Sundeep S. Salvi
    Stephen T. Holgate
    Current Allergy and Asthma Reports, 2001, 1 (2) : 100 - 101
  • [43] The role of anti-IgE therapies in the treatment of asthma
    Babu, KS
    Holgate, ST
    HOSPITAL MEDICINE, 2002, 63 (08): : 483 - 486
  • [44] Anti-IL-5 treatments in patients with severe asthma by blood eosinophil thresholds: Indirect treatment comparison
    Busse, William
    Chupp, Geoffrey
    Nagase, Hiroyuki
    Albers, Frank C.
    Doyle, Scott
    Shen, Qin
    Bratton, Daniel J.
    Gunsoy, Necdet B.
    JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 2019, 143 (01) : 190 - +
  • [45] Anti-IL-5 and anti-IL-5R biologics for severe asthma. Are there any differences in their effects?
    Granda, Paula
    Villamanan, Elena
    Carpio, Carlos
    Laorden, Daniel
    Quirce, Santiago
    alvarez-Sala, Rodolfo
    JOURNAL OF ASTHMA, 2024, 61 (08) : 857 - 866
  • [46] Targeting the IL-5 pathway in eosinophilic asthma: A comparison of anti-IL-5 versus anti-IL-5 receptor agents (vol 79, pg 2943, 2024)
    Jackson, D. J.
    Wechsler, M. E.
    Brusselle, G.
    Buhl, R.
    ALLERGY, 2025,
  • [47] Real World Effectiveness And Safety Of Anti-Il-5/mepolizumab In An Academic Severe Asthma Clinic
    Zhang, P.
    Vitari, C. A.
    Wenzel, S. E.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2017, 195
  • [48] Changes in Serum MicroRNAs after Anti-IL-5 Biological Treatment of Severe Asthma
    Rial, Manuel J.
    Canas, Jose A.
    Rodrigo-Munoz, Jose M.
    Valverde-Monge, Marcela
    Sastre, Beatriz
    Sastre, Joaquin
    del Pozo, Victoria
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2021, 22 (07)
  • [49] Overall Response to Anti-IL-5/Anti-IL5-Ra Treatment in Severe Asthma Does Not Depend on Initial Bronchodilator Responsiveness
    Muemmler, Carlo
    Suhling, Hendrik
    Walter, Julia
    Kneidinger, Nikolaus
    Buhl, Roland
    Kayser, Moritz Z.
    Drick, Nora
    Behr, Juergen
    Welte, Tobias
    Korn, Stephanie
    Milger, Katrin
    JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY-IN PRACTICE, 2022, 10 (12): : 3174 - 3183
  • [50] Cost-effectiveness analysis of anti-IL-5 therapies of severe eosinophilic asthma in Spain
    Gonzalez-Barcala, Francisco Javier
    Munoz-Gall, Xavier
    Mariscal, Esther
    Garcia, Andrea
    Yang, Shibing
    van de Wetering, Gijs
    Izquierdo-Alonso, Jose Luis
    JOURNAL OF MEDICAL ECONOMICS, 2021, 24 (01) : 874 - 882
12345